IP Verse

T Cell Receptors - EP3440104

The patent EP3440104 was granted to Adaptimmune on Jun 14, 2023. The application was originally filed on Apr 10, 2017 under application number EP17716871A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3440104

ADAPTIMMUNE
Application Number
EP17716871A
Filing Date
Apr 10, 2017
Status
Patent Maintained As Amended
May 12, 2023
Grant Date
Jun 14, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR H ULRICH DORRIESDec 11, 2020DORRIESADMISSIBLE
DR H ULRICH DORRIESDec 11, 2020DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS6596536
INTERNATIONAL-SEARCH-REPORTWO02094981
INTERNATIONAL-SEARCH-REPORTWO2014201021
OPPOSITIONEP1117679
OPPOSITIONUS2005053918
OPPOSITIONWO02094981
OPPOSITIONWO2017174823

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- M.-T. DUFFOUR et al., "A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes", European Journal of Immunology, (19991000), vol. 29, no. 10, pages 3329 - 3337, XP002630782-
OPPOSITION- BARNEA et al., "Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens", European journal of immunology, (20020122), vol. 32, no. 1, pages 213 - 222, XP002903216
OPPOSITION- HILLIG et al., "High-resolution structure of HLA-A∗0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene", Journal of molecular biology, (20010727), vol. 310, no. 5, pages 1167 - 1176, XP004466111
OPPOSITION- N.M. HOSSAIN et al., "T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies", Current hematologic malignancy reports, (20160419), vol. 11, no. 4, pages 311 - 317, XP035989473
OPPOSITION- J.L. WEON et al., "The MAGE protein family and cancer", Current opinion in cell biology, (20150903), vol. 37, pages 1 - 8, XP029343219
OPPOSITION- LINNEMAN, "T-Cell Receptor Gene Therapy: Critical Parameters for Clinical Success", The Journal of investigative dermatology, (20110616), vol. 131, no. 9, pages 1806 - 1816, XP055108738
OPPOSITION- COLE et al., "T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions", The Journal of biological chemistry, (20131106), vol. 289, no. 2, pages 628 - 638, XP055273969
OPPOSITION- Y. SHIRAKURA et al., "T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice", Cancer Science, (20111108), vol. 103, no. 1, pages 17 - 25, XP055386209
OPPOSITION- S.A. ROSENBERG et al., "Adoptive cell transfer as personalized immunotherapy for human cancer", Science, (20150403), vol. 348, no. 6230, pages 62 - 68, XP055256712
OPPOSITION- CONNEROTTE T. et al., "Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities", Cancer research, (20080515), vol. 68, no. 10, pages 3931 - 3940, XP002571598
OPPOSITION- G. PETROVA et al., "Cross-Reactivity of T Cells and Its Role in the Immune System", Critical Reviews in Immunology, (20120101), vol. 32, no. 4, pages 349 - 372, XP055578532
OPPOSITION- ZOETE V. et al., "Structure-based, rational design of T cell receptors", Frontiers in immunology, (20130912), vol. 4, page 268, XP055762780

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents